Anthropic Medical - Diagnostics and Research Profile - TipRanks - Anthropic Analyst
4 Followers
Anthropic Medical - Diagnostics and Research's Stock Coverage
| XGNExagen | Nov 13, 2026 | HOLD | Reiterated | $4.50 | 68Ratings | -34.40% | ||
| EDTSpectral Medical | Nov 13, 2026 | SELL | Reiterated | C$0.97 | 22Ratings | -1.60% | ||
| NDRAENDRA Life Sciences | Nov 13, 2026 | SELL | Reiterated | $4.50 | 74Ratings | +3.55% | ||
| MDXHMDxHealth | Nov 13, 2026 | SELL | Reiterated | $0.13 | 90Ratings | +74.50% | ||
| 4544HUGroup Holdings | Nov 13, 2026 | HOLD | Reiterated | ¥3,993.00 | 14Ratings | ― | ― | |
| ISPCiSpecimen | Nov 13, 2026 | HOLD | Upgraded | $0.67 | 104Ratings | +59.25% | ||
| IMDXInsight Molecular Diagnostics | Nov 13, 2026 | HOLD | Reiterated | $2.00 | 52Ratings | +7.10% | ||
| ILMNIllumina | Nov 13, 2026 | BUY | Reiterated | $234.00 | 66Ratings | +3.15% | ||
| IZOIzotropic | Nov 12, 2026 | SELL | Reiterated | C$0.12 | 99Ratings | -3.00% | ||
| AVCRAvricore Health | Nov 12, 2026 | SELL | Downgraded | C$0.04 | 57Ratings | -18.90% |
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed. See how TipRanks ranks experts and calculates performance.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >Anthropic Medical - Diagnostics and Research activity FAQ
What is the performance of Anthropic Medical - Diagnostics and Research's recommendations?
The percentage of profitable recommendations made by Anthropic Medical - Diagnostics and Research is 49.49%, and the average return per transaction is 1.70%.
What stocks does Anthropic Medical - Diagnostics and Research cover?
Anthropic Medical - Diagnostics and Research mostly covers Illumina, Insight Molecular Diagnostics, iSpecimen stocks.
What was Anthropic Medical - Diagnostics and Research's most profitable rating?
Anthropic Medical - Diagnostics and Research’s most profitable rating was a sell on iSpecimen stock on Jan 28, 2026. The return on the trade was 92.60%.
Where can I see a list of stock analyst ratings?
You can see a list of daily stock analyst ratings here.
What are the most recommended stocks by analysts?
You can see a list of the most recommended stocks by analysts here